Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Burden of Overactive Bladder on US Public Health.

Literature DB >> 27057265

The Burden of Overactive Bladder on US Public Health.

W Stuart Reynolds¹, Jay Fowke², Roger Dmochowski¹.

Abstract

Overactive bladder (OAB) is a highly prevalent symptom condition that affects millions of US men and women. Not only can the symptoms of OAB be very bothersome, but OAB can have significant detrimental effects on many aspects of individuals' lives, representing a particularly impactful health burden to quality of life and productivity. Estimates of the individual and societal costs for the management of OAB continue to rise, particularly as effective treatments remain elusive. As such, OAB represents a significant public health burden to the USA.

Entities: Disease Gene Species

Keywords: Epidemiology; Health economics; Overactive bladder; Public health

Year: 2016 PMID： 27057265 PMCID： PMC4821440 DOI： 10.1007/s11884-016-0344-9

Source DB: PubMed Journal: Curr Bladder Dysfunct Rep ISSN： 1931-7212

34 in total

Review 1. The psychological impact of overactive bladder: A systematic review.

Authors: Debbie Kinsey; Sara Pretorius; Lesley Glover; Tim Alexander
Journal: J Health Psychol Date: 2014-03-02

2. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.

Authors: Ian Milsom; Steven A Kaplan; Karin S Coyne; Chris C Sexton; Zoe S Kopp
Journal: Urology Date: 2012-07 Impact factor: 2.649

Review 3. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment.

Authors: E Ann Gormley; Deborah J Lightner; Martha Faraday; Sandip Prasan Vasavada
Journal: J Urol Date: 2015-01-23 Impact factor: 7.450

4. Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study.

Authors: Karin S Coyne; Mary Kay Margolis; Zoe S Kopp; Steven A Kaplan
Journal: Urology Date: 2011-11-04 Impact factor: 2.649

5. The "costs" of urinary incontinence for women.

Authors: Leslee L Subak; Jeanette S Brown; Stephen R Kraus; Linda Brubaker; Feng Lin; Holly E Richter; Catherine S Bradley; Deborah Grady
Journal: Obstet Gynecol Date: 2006-04 Impact factor: 7.661

6. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.

Authors: Derek H Tang; Danielle C Colayco; Kristin M Khalaf; James Piercy; Vaishali Patel; Denise Globe; David Ginsberg
Journal: BJU Int Date: 2014-03 Impact factor: 5.588

7. Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder.

Authors: Michael B Chancellor; Kristen Migliaccio-Walle; Thomas J Bramley; Sham L Chaudhari; Catherine Corbell; Denise Globe
Journal: Clin Ther Date: 2013-10-03 Impact factor: 3.393

8. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL.

Authors: Karin S Coyne; Chris C Sexton; Jill A Bell; Christine L Thompson; Roger Dmochowski; Tamara Bavendam; Chieh-I Chen; J Quentin Clemens
Journal: Neurourol Urodyn Date: 2012-07-27 Impact factor: 2.696

9. Prevalence and burden of overactive bladder in the United States.

Authors: W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal: World J Urol Date: 2002-11-15 Impact factor: 4.226

10. Patient-reported reasons for discontinuing overactive bladder medication.

Authors: Joshua S Benner; Michael B Nichol; Eric S Rovner; Zhanna Jumadilova; Jose Alvir; Mohamed Hussein; Kristina Fanning; Jeffrey N Trocio; Linda Brubaker
Journal: BJU Int Date: 2009-11-12 Impact factor: 5.588

27 in total

1. Temporal summation to thermal stimuli is elevated in women with overactive bladder syndrome.

Authors: William Stuart Reynolds; Elizabeth Timbrook Brown; Jill Danford; Melissa Kaufman; Alan Wein; Roger Dmochowski; Stephen Bruehl
Journal: Neurourol Urodyn Date: 2016-07-19 Impact factor: 2.696

Review 2. Lower urinary tract symptoms treatment constraints assessment (LUTS-TCA): a new tool for a global evaluation of neurogenic bladder treatments.

Authors: Nicolas Turmel; Pierre Lévy; Claire Hentzen; Camille Chesnel; Audrey Charlanes; Samer Sheikh-Ismael; Gérard Amarenco; Philippe Manceau
Journal: World J Urol Date: 2018-12-04 Impact factor: 4.226

3. Efficacy of Transcutaneous Electrical Nerve Stimulation in the Treatment of Overactive Bladder.

Authors: Nidhi Sharma; Kaja Rekha; Krishnamurthy Jayashree Srinivasan
Journal: J Clin Diagn Res Date: 2016-10-01

4. Racial Differences in Urinary Incontinence Prevalence, Overactive Bladder and Associated Bother among Men: The Multi-Ethnic Study of Atherosclerosis.

Authors: Aelia Akbar; Kiang Liu; Erin D Michos; Linda Brubaker; Talar Markossian; Michael P Bancks; Holly Kramer
Journal: J Urol Date: 2020-09-10 Impact factor: 7.450

Review 5. Cognitive-behavioral therapy and urge urinary incontinence in women. A systematic review.

Authors: Benoit Steenstrup; Floriane Lopes; Jean Nicolas Cornu; Maxime Gilliaux
Journal: Int Urogynecol J Date: 2021-10-30 Impact factor: 1.932

6. Effectiveness of an intervention to optimise the use of mirabegron for overactive bladder: a quasi-experimental study in primary care.

Authors: Eladio Fernández-Liz; Pere Vivó Tristante; Antonio Aranzana Martínez; Maria Estrella Barceló Colomer; Josep Ossó Rebull; Maria Josep López Dolcet
Journal: Br J Gen Pract Date: 2018-11-19 Impact factor: 5.386

7. Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors: Aelia Akbar; Kiang Liu; Erin D Michos; Michael P Bancks; Linda Brubaker; Talar Markossian; Ramon Durazo-Arvizu; Holly Kramer
Journal: Am J Hypertens Date: 2022-01-05 Impact factor: 2.689